Innovation for Health - 13 February 2020
Innovation for Health - Shaping the future of healthcare

Edward van Wezel

Managing partner & Founder, BioGeneration Ventures

Edward van Wezel is managing partner and founder of BioGeneration Ventures. Edward has extensive international expertise in small and large pharma and biotech companies. Edward currently serves on the the boards of NovioGendix, Progentix Orthobiology, Cristal Therapeutics and Acerta Pharma. He served on the board of BioCeros that was sold in 2011. Edward started his industrial career as process engineer for Chiron Inc. and working for Johnson & Johnson as project manager. At J&J he was responsible for preclinical and Phase II product development projects in the oncology franchise. In addition he was involved in in-licensing activities. Since 2000 he gained experience in several small start-up and early stage companies in the Netherlands. He was director business development at Pepscan Systems and managing director of Macrozyme. At Macrozyme Edward was responsible for the complete pre-clinical development of a new chemical entity that under his responsibility was successfully partnered with Genzyme Inc. in 2005. Edward holds a M.Sc in chemistry from the University of Utrecht and a M.Sc in biochemical engineering from the Delft University of Technology.

Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Platinum sponsor
Gold sponsor
Silver sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Media sponsor
Powered by
Hyphen Projects
© 2020 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.
By continuing to use this site, you consent to our use of cookies. For more information, read: